Antiviral Effects of Ophthalmic Formulations
Corresponding Organization : University of Salerno
Other organizations : University of Campania "Luigi Vanvitelli", Ospedali Riuniti San Giovanni di Dio e Ruggi d'Aragona
Variable analysis
- Oftasecur eye drops (selected volumes)
- Visuprime eye drops (selected volumes)
- Viral suspension at a density of 2 × 10^3 PFU/mL (co-treatment and cell pre-treatment)
- Viral suspension at a density of 2 × 10^4 PFU/mL (virus pre-treatment)
- Exposure time of 1-10-30 min and 1 h (virus pre-treatment)
- Plaque reduction in infected cells
- Fluorescence intensity (GFP-engineered HSV-1)
- DMEM without FBS
- Cell monolayer
- Incubation temperature of 37 °C
- Incubation time of 1 h for viral adsorption
- Melittin (5 µM) in co-treatment and virus pre-treatment
- Dextran-sulfate (1 µM) in cell pre-treatment
- Aciclovir (5 µM) in post-treatment
- Uninfected cells
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!